Reduced VEGF Production, Angiogenesis, and Vascular Regrowth Contribute to the Antitumor Properties of Dual mTORC1/mTORC2 Inhibitors

Beverly L. Falcón(University of California, San Francisco), Donald M. McDonald(PDL BioPharma (United States))
Cancer Research
March 1, 2011
Cited by 91


Related Papers